simplywall.st Earnings
News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 1–36
- Matches
- 5973
- Sources here
- 10
- Companies here
- 26
Active search
5973 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Rocket Lab Satellite Platforms Built for MDA Space Successfully Reach Orbit, Supporting Globalstar Direct-to-Device Communications Services
Rocket Lab Corporation Rocket Lab Lightning BusRocket Lab Satellite Platforms Built for MDA Space Successfully Reach Orbit, Supporting Globalstar Direct-to-Device Communications Services LONG BEACH, Calif., Aug. 16, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (Nasdaq: RKLB), a global leader in launch services and space …
Sharemaestro market context Trend signal started 52 weeks +10.5% · Next-week setup positive 59.2%GE Aerospace Stock Is Up 26% in Three Months. Here’s What Actually Moved It.
GE Aerospace stock has risen 26% in three months, primarily driven by a strong Q2 earnings report on July 16, 2026, which included an EPS beat, significant revenue growth, and raised full-year guidance. The company's large backlog, especially in Commercial Services, and new engine …
Space is becoming an institutional asset class, Goldman says
[Rocket flies through the clouds] Alexyz3d/iStock via Getty Images Space is moving from a government-led frontier to an institutional asset class, as falling launch costs, private investment and public-market funding reshape the orbital economy, according to the Goldman Sachs Global Institute. In a report …
Sharemaestro market context Stored weekly price path 10 weeks -13.0% · Next-week setup negative 35.2%Why Tarsus Pharmaceuticals (TARS) Is Up 6.8% After Raising XDEMVY 2026 Sales Guidance - And What's Next
Tarsus Pharmaceuticals (TARS) saw its stock rise by 6.8% after reporting strong second-quarter 2026 results and raising its 2026 XDEMVY net product sales guidance to US$685 million–US$705 million. This increase signals management's confidence in XDEMVY's commercial trajectory, though the company still faces risks associated …
Total common shares outstanding of Howmet Aerospace Inc. – BCS:HWM1
This article focuses on the total common shares outstanding of Howmet Aerospace Inc., identified by the ticker BCS:HWM1 on the Santiago Stock Exchange. It appears to be a financial data point provided by TradingView, indicating that the market for this stock is currently closed …
MDA SPACE SATELLITES FOR GLOBALSTAR SUCCESSFULLY LAUNCHED
First set of eight satellites for Globalstar 2-R mission deployed to low Earth orbit on a SpaceX Falcon 9 rocket, marking the beginning of the commissioning phase TORONTO, Aug. 16, 2026 /CNW/ -- MDA Space Ltd. (TSX: MDA) (NYSE: MDA), a leading provider of …
Sharemaestro market context Stored weekly price path 10 weeks -13.0% · Next-week setup negative 35.2%Private Advisory Group LLC Makes New $6.77 Million Investment in Howmet Aerospace Inc. $HWM
Private Advisory Group LLC has made a new $6.77 million investment in Howmet Aerospace Inc., purchasing 25,188 shares. Institutional investors and hedge funds now collectively own 90.46% of the company, which has seen strong analyst recommendations and recently exceeded quarterly earnings expectations with a …
BioMarin Pharmaceutical (BMRN) Updates Guidance And Files Shelf Registration, Is It Still Below Fair Value?
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. BioMarin Pharmaceutical (BMRN) has just given investors a packed update, including second quarter 2026 results, fresh earnings guidance for the rest of the …
Sharemaestro market context New activity signal 52 weeks +11.9% · Next-week setup negative 4.6%SFE Investment Counsel Takes $2.98 Million Position in Honeywell Aerospace $HONA
SFE Investment Counsel has acquired a new position in Honeywell Aerospace (NASDAQ:HONA), purchasing 13,482 shares valued at approximately $2.98 million during the second quarter. Other institutional investors also initiated stakes in the company, while analyst sentiment remains mixed, resulting in a consensus "Hold" rating …
USA Financial Formulas Acquires New Position in Regeneron Pharmaceuticals, Inc. $REGN
USA Financial Formulas has acquired a new stake in Regeneron Pharmaceuticals (NASDAQ:REGN), purchasing 1,457 shares valued at approximately $1.13 million, making it their 27th-largest portfolio holding. Institutional investors collectively own 83.31% of Regeneron, with several major firms significantly increasing their positions. The company recently …
Net margin % of Howmet Aerospace Inc. – BCS:HWM1
This article displays the net margin percentage for Howmet Aerospace Inc. (BCS:HWM1) on the TradingView platform. It provides a financial overview of the company, showing its performance over different periods. The content is primarily a data display from a financial platform, without additional analysis …
Book value per share of Howmet Aerospace Inc. – BCS:HWM1
This article provides financial information for Howmet Aerospace Inc. (BCS:HWM1) on the Santiago Stock Exchange, specifically focusing on its book value per share. It appears to be a stub or a data point from a larger financial platform like TradingView, indicating no current trading …
Focus Partners Advisor Solutions LLC Takes Position in Honeywell Aerospace $HONA
Focus Partners Advisor Solutions LLC has acquired a new position in Honeywell Aerospace (NASDAQ: HONA), purchasing 6,993 shares valued at approximately $1.55 million in the second quarter. Several other institutional investors also initiated new stakes in the company. Analysts have a consensus "Hold" rating …
Debt to equity ratio of Howmet Aerospace Inc. – BCS:HWM1
This article focuses on the debt to equity ratio of Howmet Aerospace Inc. (BCS:HWM1), a company listed on the Santiago Stock Exchange under the Electronic Technology and Aerospace & Defense sectors. The content highlights the financial overview of HWM1, specifically mentioning the debt-to-equity ratio …
Ionis (IONS) Stock Looks Like A Bargain On Value But Full On Sales
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Ionis Pharmaceuticals stock carries a strong three year return record alongside a high overall value score, yet current market multiples still point to the shares …
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Rating of "Moderate Buy" by Brokerages
Tarsus Pharmaceuticals (NASDAQ:TARS) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $90.50, significantly higher than its current share price of $69.20. The company recently reported quarterly revenue of $173.91 million, surpassing estimates, but its loss per …
Will Mirum Pharmaceuticals' (MIRM) Widening Net Losses Test Its Growth-Focused Investment Narrative?
Mirum Pharmaceuticals reported a significant net loss for Q2 and H1 2026, with basic loss per share rising, which highlights increased costs relative to revenue. This widening loss intensifies focus on cash burn and funding risks, despite upcoming clinical and regulatory catalysts such as …
Wall Street Zen Downgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Sell
Wall Street Zen has downgraded Mirum Pharmaceuticals (NASDAQ:MIRM) from "hold" to "sell," despite the company reporting better-than-expected quarterly revenue of $176.24 million, a 37.9% increase year-over-year. The downgrade comes as the company missed earnings per share estimates, reporting a loss of $1.06 against a …
Responsive Playbooks and the ETON Inflection
This article provides an AI-driven analysis for Eton Pharmaceuticals Inc. (NASDAQ: ETON), highlighting weak near and mid-term sentiment but a positive long-term outlook. It details specific trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report suggests …
Why Eton Pharmaceuticals (ETON) Is Up 32.0% After Q2 Earnings Surge And Raised 2026 Outlook
Eton Pharmaceuticals (ETON) saw its stock rise 32.0% after reporting a significant Q2 2026 earnings turnaround, with revenue surging to US$37.59 million and net income reaching US$11.58 million. The company also raised its full-year 2026 revenue guidance to at least US$145 million and expanded …
Enterprise value to revenue forward of Rhythm Pharmaceuticals, Inc. – DUS:1RV
This article provides financial data for Rhythm Pharmaceuticals, Inc. (DUS:1RV) on the Dusseldorf Stock Exchange, specifically focusing on its enterprise value to revenue forward. It notes that the market is closed with no trades recorded at the time of publication. The content is presented …
Price to book forward of Howmet Aerospace Inc. – BCS:HWM1
This article provides financial information for Howmet Aerospace Inc. (BCS:HWM1) on the Santiago Stock Exchange, specifically focusing on its price-to-book forward ratio. It appears to be a stub or data page from TradingView, offering an overview of the company's financials without detailed analysis.
SpaceX Stock Is Down 33% From Its High. Elon Musk Expects Revenue to Rise 53-Fold to $1 Trillion by 2030.
Space Exploration Technologies (NASDAQ: SPCX) generated $18.7 billion in revenue in 2025. Chief Executive Officer Elon Musk just predicted that the company will hit $100 billion in annual recurring revenue (ARR) by the end of this year, and $1 trillion in revenue by 2030. …